BACKGROUND/RATIONALE:
Dr. Humphreys' research focuses on the evaluation of interventions and policies affecting individuals with substance use disorders. This work comprises studies of professionally-delivered treatments, self-administered interventions (e.g., Internet-based brief interventions for problem drinking), and peer-led self-help groups (e.g., Alcoholics Anonymous). A consistent theme in all this work is the use of science to guide front line practice and higher level health system organization, including researching the implications of the differences between individuals who seek care versus those who participate in treatment research studies, and, examination of evidenced-informed public policies that can reduce addiction and the damage it causes at the population level.

OBJECTIVE(S):
The objectives of Dr. Humphreys' work are to conduct high quality health services research related to substance use disorders, to mentor early career investigators, and to contribute to better policies and practices concerning addiction in the VA and in other health care systems as well.

METHODS:
The methods employed vary depending on the study Dr. Humphreys is conducting. His research on self-administered Internet-based interventions are randomized clinical trials. His research on peer-led self-help programs tends to be naturalistic, prospective longitudinal studies. His studies of the representativeness of treatment research samples are archival studies of prior research and simulation studies using secondary data analysis.

FINDINGS/RESULTS:
Not yet available.

IMPACT:
Dr. Humphreys' research on treatment and substance use was widely cited by other scientists, and has been acknowledged as an influence on substance use related legislation on the floor of the UK House of Lords and the West Virginia Senate. Dr. Humphreys' work leading the re-design of VA's national system of substance use disorder care after the commencement of military action in Iraq and Afghanistan continues to shape the system and continues to be used by VA care planners nationally. Dr. Humphreys is also making a national contribution to the care of people with substance use disorders through his work with the U.S. Surgeon General and internationally through his work with the World Health Organization.

PUBLICATIONS:

Journal Articles

1. Roberts E, Copeland C, Humphreys K, Shover CL. Drug-related deaths among housed and homeless individuals in the UK and the USA: comparative retrospective cohort study. The British journal of psychiatry : the journal of mental science. 2023 Dec 1; 223(6):562-568.
2. Durazzo TC, Humphreys K, LaRocca MA. Leadership Styles Experienced During Military Service Predict Later Anhedonic Depressive Symptoms and Self-Efficacy in Veterans With Alcohol Use Disorder. Military medicine. 2023 Oct 28.
3. Wang Z, Mueller JF, O'Brien JW, Thompson J, Tscharke BJ, Verhagen R, Zheng Q, Prichard J, Hall W, Humphreys K, Thomas KV, Thai PK. Monitoring medication and illicit drug consumption in a prison by wastewater-based epidemiology: Impact of COVID-19 restrictions. Water research. 2023 Oct 1; 244:120452.
4. El Hajouji O, Sun RS, Zammit A, Humphreys K, Asch SM, Carroll I, Curtin CM, Hernandez-Boussard T. Prediction of opioid-related outcomes in a medicaid surgical population: Evidence to guide postoperative opiate therapy and monitoring. PLoS computational biology. 2023 Aug 1; 19(8):e1011376.
5. Roberts E, Humphreys K. Does the advent of depot therapy represent a step change in our understanding of opioid use disorder and its treatment? Drug and Alcohol Review. 2023 Jul 31.
6. Joyce VR, Oliva EM, Garcia CC, Trafton J, Asch SM, Wagner TH, Humphreys K, Owens DK, Bounthavong M. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder. Addiction (Abingdon, England). 2023 Nov 1; 118(11):2203-2214.
7. Trivedi R, Hirayama SK, Risbud R, Suresh M, Humber MB, Butler K, Razze A, Timko C, Nelson K, Zulman DM, Asch SM, Humphreys K, Piette JD. Adapting a Telephone-Based, Dyadic Self-management Program to Be Delivered Over the Web: Methodology and Usability Testing. JMIR formative research. 2023 Jun 16; 7:e43903.
8. Zhu DT, Tamang S, Humphreys K. Promises and perils of the FDA's over-the-counter naloxone reclassification. Lancet Regional Health. Americas. 2023 Jul 1; 23:100518.
9. Claypool AL, DiGennaro C, Russell WA, Yildirim MF, Zhang AF, Reid Z, Stringfellow EJ, Bearnot B, Schackman BR, Humphreys K, Jalali MS. Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids. JAMA health forum. 2023 May 5; 4(5):e231080.
10. Humphreys K, Shover CL. Twenty-Year Trends in Drug Overdose Fatalities Among Older Adults in the US. JAMA psychiatry. 2023 May 1; 80(5):518-520.
11. Fast N, van Kessel R, Humphreys K, Ward NF, Roman-Urrestarazu A. The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review. Current addiction reports. 2023 Apr 25; 10(2):187-197.
12. Dhinsa J, Roman-Urrestarazu A, van Kessel R, Humphreys K. Understanding predictors of mental health and substance use treatment utilization among US adults: A repeated cross-sectional study. Global epidemiology. 2023 Dec 1; 5:100109.
13. Roberts E, Humphreys K. "Safe Supply" Initiatives: Are They a Recipe for Harm Through Reduced Health Care Input and Supply-Induced Toxicity and Overdose? Journal of studies on alcohol and drugs. 2023 Jul 1; 84(4):644-647.
14. Stringfellow EJ, Lim TY, DiGennaro C, Zhang Z, Paramasivam P, Bearnot B, Humphreys K, Jalali MS. Long-Term Effects of Increasing Buprenorphine Treatment Seeking, Duration, and Capacity on Opioid Overdose Fatalities: A Model-based Analysis. Journal of addiction medicine. 2023 Jul 1; 17(4):439-446.
15. Elser H, Humphreys K, Kiang MV, Mehta S, Yoon JH, Faustman WO, Matthay EC. State Cannabis Legalization and Psychosis-Related Health Care Utilization. JAMA Network Open. 2023 Jan 3; 6(1):e2252689.
16. Qian G, Rao I, Humphreys K, Owens DK, Brandeau ML. Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence. 2023 Feb 1; 243:109762.
17. Coquet J, Zammit A, Hajouji OE, Humphreys K, Asch SM, Osborne TF, Curtin CM, Hernandez-Boussard T. Changes in postoperative opioid prescribing across three diverse healthcare systems, 2010-2020. Frontiers in digital health. 2022 Dec 6; 4:995497.
18. Salmasi V, Lii TR, Humphreys K, Reddy V, Mackey SC. A literature review of the impact of exclusion criteria on generalizability of clinical trial findings to patients with chronic pain. Pain reports. 2022 Nov 11; 7(6):e1050.
19. Hall WD, Humphreys K. Is good science leading the way in the therapeutic use of psychedelic drugs? Psychological medicine. 2022 Oct 1; 52(14):2849-2851.
20. Cucciare MA, Abraham TH, Kemp L, White P, Marchant K, Hagedorn HJ, Humphreys K. Adapting the Eliminating Medications Through Patient Ownership of End Results Protocol to Promote Benzodiazepine Cessation Among US Military Veterans: Focus Group Study With US Military Veterans and National Veterans Health Administration Leaders. Journal of medical Internet research. 2022 Sep 19; 24(9):e35514.
21. Marsden J, Brown J, Clark L, Cousijn J, Hall W, Hickman M, Holmes J, Humphreys K, Jackson SE, Peacock A, Tucker J. The impact of the COVID-19 pandemic on addictive disorders-an update. Addiction (Abingdon, England). 2022 Nov 1; 117(11):2762-2766.
22. Cucciare MA, Hagedorn HJ, Bounthavong M, Abraham TH, Greene CJ, Han X, Kemp L, Marchant K, White P, Humphreys K. Promoting benzodiazepine cessation through an electronically-delivered patient self-management intervention (EMPOWER-ED): Randomized controlled trial protocol. Contemporary clinical trials communications. 2022 Oct 1; 29:100994.
23. Stringfellow EJ, Lim TY, Humphreys K, DiGennaro C, Stafford C, Beaulieu E, Homer J, Wakeland W, Bearnot B, McHugh RK, Kelly J, Glos L, Eggers SL, Kazemi R, Jalali MS. Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis. Science advances. 2022 Jun 24; 8(25):eabm8147.
24. Lim TY, Stringfellow EJ, Stafford CA, DiGennaro C, Homer JB, Wakeland W, Eggers SL, Kazemi R, Glos L, Ewing EG, Bannister CB, Humphreys K, Throckmorton DC, Jalali MS. Modeling the evolution of the US opioid crisis for national policy development. Proceedings of the National Academy of Sciences of the United States of America. 2022 Jun 7; 119(23):e2115714119.
25. Humphreys K, Marsden J. Responding to 100?000 annual drug overdose deaths in the United States: a special section of commentaries. Addiction (Abingdon, England). 2022 May 1; 117(5):1187.
26. Humphreys K, Marsden J. Synthesizing advice to the United States from other nations that have experienced drug epidemics. Addiction (Abingdon, England). 2022 May 1; 117(5):1202-1203.
27. Kiang MV, Acosta RJ, Chen YH, Matthay EC, Tsai AC, Basu S, Glymour MM, Bibbins-Domingo K, Humphreys K, Arthur KN. Sociodemographic and geographic disparities in excess fatal drug overdoses during the COVID-19 pandemic in California: A population-based study. Lancet Regional Health. Americas. 2022 Jul 1; 11:100237.
28. Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, Chen JH, Cuéllar MF, Hurd YL, Juurlink DN, Koh HK, Krebs EE, Lembke A, Mackey SC, Larrimore Ouellette L, Suffoletto B, Timko C. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet (London, England). 2022 Feb 5; 399(10324):555-604.
29. Vest NA, Rossi FS, Ilgen M, Humphreys K, Timko C. Substance Use, PTSD Symptoms, and Suicidal Ideation Among Veteran Psychiatry Inpatients: A Latent Class Trajectory Analysis. Journal of studies on alcohol and drugs. 2021 Nov 1; 82(6):792-800.
30. Kiang MV, Barnett ML, Wakeman SE, Humphreys K, Tsai AC. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States. Drug and Alcohol Dependence. 2021 Nov 1; 228:109081.
31. Shover CL, Falasinnu TO, Freedman RB, Humphreys K. Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study. Journal of addiction medicine. 2021 Sep 1; 15(5):429-431.
32. Frank RG, Humphreys KN, Pollack HA. Policy Responses to the Addiction Crisis. Journal of Health Politics, Policy and Law. 2021 Aug 1; 46(4):585-597.
33. Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, Goldhaber-Fiebert JD, Asch SM, Brandeau ML, Owens DK. Cost-effectiveness of Treatments for Opioid Use Disorder. JAMA psychiatry. 2021 Jul 1; 78(7):767-777.
34. Vest N, Reinstra M, Timko C, Kelly J, Humphreys K. College programming for students in addiction recovery: A PRISMA-guided scoping review. Addictive Behaviors. 2021 Oct 1; 121:106992.
35. Bentzley BS, Han SS, Neuner S, Humphreys K, Kampman KM, Halpern CH. Comparison of Treatments for Cocaine Use Disorder Among Adults: A Systematic Review and Meta-analysis. JAMA Network Open. 2021 May 3; 4(5):e218049.
36. Matthay EC, Kiang MV, Elser H, Schmidt L, Humphreys K. Evaluation of State Cannabis Laws and Rates of Self-harm and Assault. JAMA Network Open. 2021 Mar 1; 4(3):e211955.
37. Baum A, Bazemore A, Peterson L, Basu S, Humphreys K, Phillips RL. Primary Care Physicians and Spending on Low-Value Care. Annals of internal medicine. 2021 Jun 1; 174(6):875-878.
38. Baum LVM, Bruzelius E, Kiang MV, Humphreys K, Basu S, Baum A. Analysis of unused prescription opioids and benzodiazepines remaining after death among Medicare decedents. Drug and Alcohol Dependence. 2021 Feb 1; 219:108502.
39. Becker WC, Humphreys K, Atkins D, Clancy CM. Mounting a Scientifically Informed Response to the Opioid Crisis in the Veterans Health Administration. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):883-885.
40. Vest N, Sox-Harris A, Ilgen M, Humphreys K, Timko C. Depression, Alcoholics Anonymous Involvement, and Daily Drinking Among Patients with co-occurring Conditions: A Longitudinal Parallel Growth Mixture Model. Alcoholism, clinical and experimental research. 2020 Dec 1; 44(12):2570-2578.
41. Kelly JF, Abry A, Ferri M, Humphreys K. Alcoholics Anonymous and 12-Step Facilitation Treatments for Alcohol Use Disorder: A Distillation of a 2020 Cochrane Review for Clinicians and Policy Makers. Alcohol and alcoholism (Oxford, Oxfordshire). 2020 Oct 20; 55(6):641-651.
42. Humphreys K. Will hope triumph over experience in pharmacotherapy research on cocaine use disorder? Addiction (Abingdon, England). 2021 Apr 1; 116(4):712-714.
43. Cucciare MA, Combs AS, Joshi G, Han X, Humphreys K. Computer-delivered brief alcohol intervention for patients with liver disease: a randomized controlled trial. Addiction (Abingdon, England). 2021 May 1; 116(5):1076-1087.
44. Shover CL, Falasinnu TO, Dwyer CL, Santos NB, Cunningham NJ, Freedman RB, Vest NA, Humphreys K. Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance. Drug and Alcohol Dependence. 2020 Nov 1; 216:108314.
45. Park SE, Mosley JE, Grogan CM, Pollack HA, Humphreys K, D'Aunno T, Friedmann PD. Patient-centered care's relationship with substance use disorder treatment utilization. Journal of substance abuse treatment. 2020 Nov 1; 118:108125.
46. Humphreys K, Barreto NB, Alessi SM, Carroll KM, Crits-Christoph P, Donovan DM, Kelly JF, Schottenfeld RS, Timko C, Wagner TH. Impact of 12 step mutual help groups on drug use disorder patients across six clinical trials. Drug and Alcohol Dependence. 2020 Oct 1; 215:108213.
47. Andrews CM, Humphreys K. Investing in Community Health Centers to Expand Addiction Treatment. Psychiatric services (Washington, D.C.). 2020 Jul 1; 71(7):647.
48. Shover CL, Vest NA, Chen D, Stueber A, Falasinnu TO, Hah JM, Kim J, Mackey I, Weber KA, Ziadni M, Humphreys K. Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication. JAMA Network Open. 2020 Jul 1; 3(7):e2010001.
49. Blonigen DM, Harris-Olenak B, Kuhn E, Timko C, Humphreys K, Smith JS, Dulin P. Using peers to increase veterans' engagement in a smartphone application for unhealthy alcohol use: A pilot study of acceptability and utility. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2021 Nov 1; 35(7):829-839.
50. Shover CL, Humphreys K. Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model? Cureus. 2020 Jun 17; 12(6):e8671.
51. Humphreys K, Shover CL. Recreational cannabis legalization presents an opportunity to reduce the harms of the US medical cannabis industry. World psychiatry : official journal of the World Psychiatric Association (WPA). 2020 Jun 1; 19(2):191-192.
52. Nguyen LC, Durazzo TC, Dwyer CL, Rauch AA, Humphreys K, Williams LM, Padula CB. Predicting relapse after alcohol use disorder treatment in a high-risk cohort: The roles of anhedonia and smoking. Journal of psychiatric research. 2020 Jul 1; 126:1-7.
53. Marsden J, Darke S, Hall W, Hickman M, Holmes J, Humphreys K, Neale J, Tucker J, West R. Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction (Abingdon, England). 2020 Jun 1; 115(6):1007-1010.
54. Humphreys K, Kilmer B. Still HOPEful: Reconsidering a "failed" replication of a swift, certain, and fair approach to reducing substance use among individuals under criminal justice supervision. Addiction (Abingdon, England). 2020 Oct 1; 115(10):1973-1977.
55. Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. The Cochrane database of systematic reviews. 2020 Mar 11; 3:CD012880.
56. Blonigen D, Harris-Olenak B, Kuhn E, Humphreys K, Timko C, Dulin P. From "Step Away" to "Stand Down": Tailoring a Smartphone App for Self-Management of Hazardous Drinking for Veterans. JMIR mHealth and uHealth. 2020 Feb 13; 8(2):e16062.
57. Kiang MV, Humphreys K, Cullen MR, Basu S. Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study. BMJ (Clinical research ed.). 2020 Jan 29; 368:l6968.
58. Hall W, Darke S, Humphreys K, Marsden J, Neale J, West R. Addiction's policy on publishing effectiveness studies of involuntary treatment of addiction and its variants. Addiction (Abingdon, England). 2020 Oct 1; 115(10):1795-1796.
59. Pollack HA, Humphreys KN. Reducing violent incidents between police officers and people with psychiatric and/or substance use disorders. The Annals of the American Academy of Political and Social Science. 2020 Jan 1; 687(1):166-184.
60. Cuellar MF, Humphreys KN. The Political Economy of the Opioid Epidemic. Yale Law & Policy Review. 2020 Jan 5; 38(1):SSRN: https://ssrn.com/abstract=3503149.
61. Andrews CM, Humphreys K, Grogan CM. How Medicaid work requirements could exacerbate the opioid epidemic. The American journal of drug and alcohol abuse. 2019 Dec 4; 46(1):1-3.
62. Humphreys K, Hall WD. Reducing the risks of distortion in cannabis research. Addiction (Abingdon, England). 2020 May 1; 115(5):799-801.
63. Humphreys K. Networking: Translating Neuroscience to Public Policy. Neuron. 2019 Sep 25; 103(6):964-966.
64. Shover CL, Humphreys K. Predictors of availability of long-acting medication for opioid use disorder. Drug and Alcohol Dependence. 2019 Nov 1; 204:107586.
65. Park SE, Grogan CM, Mosley JE, Humphreys K, Pollack HA, Friedmann PD. Correlates of Patient-Centered Care Practices at U.S. Substance Use Disorder Clinics. Psychiatric services (Washington, D.C.). 2020 Jan 1; 71(1):35-42.
66. Shover CL, Abraham A, D'Aunno T, Friedmann PD, Humphreys K. The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs. Journal of substance abuse treatment. 2019 Oct 1; 105:44-50.
67. Humphreys K, Saitz R. Cannabis as a Substitute for Opioids-Reply. JAMA. 2019 Jul 16; 322(3):273-274.
68. Andrews CM, Humphreys K. Investing in Medicaid to End the Opioid Epidemic. Psychiatric services (Washington, D.C.). 2019 Jul 1; 70(7):537.
69. Goldstein KM, Bastian LA, Duan-Porter W, Gray KE, Hoggatt KJ, Kelly MM, Wilson SM, Humphreys K, Klap R, Yano EM, Huang GD. Accelerating the Growth of Evidence-Based Care for Women and Men Veterans. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2019 Jun 25; 29 Suppl 1:S2-S5.
70. Klap R, Humphreys K. Designing Studies for Sex and Gender Analyses: How Research Can Derive Clinically Useful Knowledge for Women's Health. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2019 Jun 25; 29 Suppl 1:S12-S14.
71. Tas B, Humphreys K, McDonald R, Strang J. Should we worry that take-home naloxone availability may increase opioid use? Addiction (Abingdon, England). 2019 Oct 1; 114(10):1723-1725.
72. Shover CL, Davis CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences of the United States of America. 2019 Jun 25; 116(26):12624-12626.
73. Shover CL, Humphreys K. Six policy lessons relevant to cannabis legalization. The American journal of drug and alcohol abuse. 2019 Mar 14; 45(6):698-706.
74. Darnall BD, Juurlink D, Kerns RD, Mackey S, Van Dorsten B, Humphreys K, Gonzalez-Sotomayor JA, Furlan A, Gordon AJ, Gordon DB, Hoffman DE, Katz J, Kertesz SG, Satel S, Lawhern RA, Nicholson KM, Polomano RC, Williamson OD, McAnally H, Kao MC, Schug S, Twillman R, Lewis TA, Stieg RL, Lorig K, Mallick-Searle T, West RW, Gray S, Ariens SR, Sharpe Potter J, Cowan P, Kollas CD, Laird D, Ingle B, Julian Grove J, Wilson M, Lockman K, Hodson F, Palackdharry CS, Fillingim RB, Fudin J, Barnhouse J, Manhapra A, Henson SR, Singer B, Ljosenvoor M, Griffith M, Doctor JN, Hardin K, London C, Mankowski J, Anderson A, Ellsworth L, Davis Budzinski L, Brandt B, Hartley G, Nickels Heck D, Zobrosky MJ, Cheek C, Wilson M, Laux CE, Datz G, Dunaway J, Schonfeld E, Cady M, LeDantec-Boswell T, Craigie M, Sturgeon J, Flood P, Giummarra M, Whelan J, Thorn BE, Martin RL, Schatman ME, Gregory MD, Kirz J, Robinson P, Marx JG, Stewart JR, Keck PS, Hadland SE, Murphy JL, Lumley MA, Brown KS, Leong MS, Fillman M, Broatch JW, Perez A, Watford K, Kruska K, Sophia You D, Ogbeide S, Kukucka A, Lawson S, Ray JB, Wade Martin T, Lakehomer JB, Burke A, Cohen RI, Grinspoon P, Rubenstein MS, Sutherland S, Walters K, Lovejoy T. International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering. Pain medicine (Malden, Mass.). 2019 Mar 1; 20(3):429-433.
75. Humphreys K, Saitz R. Should Physicians Recommend Replacing Opioids With Cannabis? JAMA. 2019 Feb 19; 321(7):639-640.
76. Parthipan A, Banerjee I, Humphreys K, Asch SM, Curtin C, Carroll I, Hernandez-Boussard T. Predicting inadequate postoperative pain management in depressed patients: A machine learning approach. PLoS ONE. 2019 Feb 6; 14(2):e0210575.
77. MacNiven KH, Jensen ELS, Borg N, Padula CB, Humphreys K, Knutson B. Association of Neural Responses to Drug Cues With Subsequent Relapse to Stimulant Use. JAMA Network Open. 2018 Dec 7; 1(8):e186466.
78. Blonigen DM, Harris-Olenak B, Haber JR, Kuhn E, Timko C, Humphreys K, Dulin PL. Customizing a clinical app to reduce hazardous drinking among veterans in primary care. Psychological Services. 2019 May 1; 16(2):250-254.
79. Humphreys K. Evaluating dynamic impacts of abuse-deterrent prescription opioid formulations. Addiction (Abingdon, England). 2019 Mar 1; 114(3):400-401.
80. Humphreys K, Bickel WK. Toward a Neuroscience of Long-term Recovery From Addiction. JAMA psychiatry. 2018 Sep 1; 75(9):875-876.
81. Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American journal of public health. 2018 Oct 1; 108(10):1394-1400.
82. Andrews CM, Grogan CM, Smith BT, Abraham AJ, Pollack HA, Humphreys K, Westlake MA, Friedmann PD. Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act. Health affairs (Project Hope). 2018 Aug 1; 37(8):1216-1222.
83. Humphreys K. Reconciling the Present and the Future in Opioid Prescription Policy: An Ethical Dilemma. Pain medicine (Malden, Mass.). 2018 Aug 1; 19(8):1514-1515.
84. Caputi TL, Humphreys K. Medical Marijuana Users are More Likely to Use Prescription Drugs Medically and Nonmedically. Journal of addiction medicine. 2018 Jul 1; 12(4):295-299.
85. West R, Marsden J, Humphreys K, Darke S. A revised checklist for writing up research reports. Addiction (Abingdon, England). 2018 Jun 19.
86. Young SD, Zheng K, Chu LF, Humphreys K. Internet searches for opioids predict future emergency department heroin admissions. Drug and Alcohol Dependence. 2018 Sep 1; 190:166-169.
87. Butler JM, Becker WC, Humphreys K. Big Data and the Opioid Crisis: Balancing Patient Privacy with Public Health. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 2018 Jun 1; 46(2):440-453.
88. Humphreys K. How Medicaid Can Strengthen the National Response to the Opioid Epidemic. American journal of public health. 2018 May 1; 108(5):589-590.
89. Hah J, Mackey SC, Schmidt P, McCue R, Humphreys K, Trafton J, Efron B, Clay D, Sharifzadeh Y, Ruchelli G, Goodman S, Huddleston J, Maloney WJ, Dirbas FM, Shrager J, Costouros JG, Curtin C, Carroll I. Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial. JAMA surgery. 2018 Apr 1; 153(4):303-311.
90. Lembke A, Papac J, Humphreys K. Our Other Prescription Drug Problem. The New England journal of medicine. 2018 Feb 22; 378(8):693-695.
91. Wong JJ, Jones N, Timko C, Humphreys K. Exclusion criteria and generalizability in bipolar disorder treatment trials. Contemporary clinical trials communications. 2018 Mar 1; 9:130-134.
92. Humphreys K. A public health approach to opioid addiction in North America - Author's reply. Lancet (London, England). 2018 Jan 20; 391(10117):202.
93. Tran Smith B, Seaton K, Andrews C, Grogan CM, Abraham A, Pollack H, Friedmann P, Humphreys K. Benefit requirements for substance use disorder treatment in state health insurance exchanges. The American journal of drug and alcohol abuse. 2017 Dec 20; 44(4):426-430.
94. Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedmann PD. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatric services (Washington, D.C.). 2018 Apr 1; 69(4):448-455.
95. Humphreys K, Williams LM. What can treatment research offer general practice?. The lancet. Psychiatry. 2018 Apr 1; 5(4):295-297.
96. Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017 Jul 29; 390(10093):437-439.
97. Humphreys K, Malenka RC, Knutson B, MacCoun RJ. Brains, environments, and policy responses to addiction. Science (New York, N.Y.). 2017 Jun 23; 356(6344):1237-1238.
98. Schmidt EM, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Finney JW, Humphreys K, Trafton J, Vanneman ME, Harris AHS. Predictive Validity of Outpatient Follow-up After Detoxification as a Quality Measure. Journal of addiction medicine. 2017 May 1; 11(3):205-210.
99. Humphreys K. A Review of the Impact of Exclusion Criteria on the Generalizability of Schizophrenia Treatment Research. Clinical schizophrenia & related psychoses. 2017 Apr 1; 11(1):49-57.
100. Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ (Clinical research ed.). 2017 Mar 14; 356:j760.
101. Friedmann PD, Andrews CM, Humphreys K. How ACA Repeal Would Worsen the Opioid Epidemic. The New England journal of medicine. 2017 Mar 9; 376(10):e16.
102. Finlay IG, Humphreys K. Mandatory sobriety programmes for alcohol-involved criminal offenders. Journal of The Royal Society of Medicine. 2017 Feb 1; 110(2):52-53.
103. Cucciare MA, Jamison AL, Combs AS, Joshi G, Cheung RC, Rongey C, Huggins J, Humphreys K. Adapting a computer-delivered brief alcohol intervention for veterans with Hepatitis C. Informatics for health & social care. 2017 Dec 1; 42(4):378-392.
104. Abraham AJ, Andrews CM, Grogan CM, D'Aunno T, Humphreys KN, Pollack HA, Friedmann PD. The Affordable Care Act Transformation of Substance Use Disorder Treatment. American journal of public health. 2017 Jan 1; 107(1):31-32.
105. Grogan CM, Andrews C, Abraham A, Humphreys K, Pollack HA, Smith BT, Friedmann PD. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health affairs (Project Hope). 2016 Dec 1; 35(12):2289-2296.
106. White W, Galanter M, Humphreys KN, Kelly JF. The Paucity of Attention to Narcotics Anonymous in Current Public, Professional, and Policy Responses to Rising Opioid Addiction. Alcoholism Treatment Quarterly. 2016 Oct 5; 34(4):437-462.
107. Schmidt EM, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Finney JW, Asch SM, Humphreys K, Trafton J, Vanneman M, Harris AHS. Predictive validity of a quality measure for intensive substance use disorder treatment. Substance Abuse. 2017 Jul 1; 38(3):317-323.
108. Kalinowski A, Humphreys K. Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. Addiction (Abingdon, England). 2016 Jul 1; 111(7):1293-8.
109. West R, Humphreys K. Data Notes Series. Addiction (Abingdon, England). 2016 Jul 1; 111(7):1143.
110. Goldstein-Piekarski AN, Williams LM, Humphreys K. A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on studying clinical outcomes in anxiety disorders. Translational psychiatry. 2016 Jun 28; 6(6):e847.
111. Moberg CA, Humphreys K. Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis. Drug and Alcohol Review. 2017 May 1; 36(3):378-388.
112. Lembke A, Humphreys K, Newmark J. Weighing the Risks and Benefits of Chronic Opioid Therapy. American Family Physician. 2016 Jun 15; 93(12):982-90.
113. Lembke A, Humphreys K. A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research. Tobacco Control. 2016 May 1; 25(3):261-2.
114. Bernard CL, Brandeau ML, Humphreys K, Bendavid E, Holodniy M, Weyant C, Owens DK, Goldhaber-Fiebert JD. Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States. Annals of internal medicine. 2016 Jul 5; 165(1):10-19.
115. Humphreys K. Grappling with the generalizability crisis in addiction treatment research. Addiction (Abingdon, England). 2016 Jul 1; 111(7):1141-2.
116. Finney JW, Humphreys K, Kivlahan DR, Harris AH. Excellent Patient Care Processes in Poor Hospitals? Why Hospital-Level and Patient-Level Care Quality-Outcome Relationships Can Differ. Journal of general internal medicine. 2016 Apr 1; 31 Suppl 1:74-7.
117. Humphreys K. The liability risks of naloxone access expansion should be the least of our worries. The American journal of drug and alcohol abuse. 2016 Mar 1; 42(2):115-6.
118. Vederhus JK, Clausen T, Humphreys K. Assessing understandings of substance use disorders among Norwegian treatment professionals, patients and the general public. BMC health services research. 2016 Feb 13; 16:52.
119. Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of Opioids by Different Types of Medicare Prescribers. JAMA internal medicine. 2016 Feb 1; 176(2):259-61.
120. Carroll IR, Hah JM, Barelka PL, Wang CK, Wang BM, Gillespie MJ, McCue R, Younger JW, Trafton J, Humphreys K, Goodman SB, Dirbas FM, Mackey SC. Pain Duration and Resolution following Surgery: An Inception Cohort Study. Pain medicine (Malden, Mass.). 2015 Dec 1; 16(12):2386-96.
121. Humphreys K, Blodgett JC, Roberts LW. The exclusion of people with psychiatric disorders from medical research. Journal of psychiatric research. 2015 Nov 1; 70:28-32.
122. Harris AH, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Rubinsky AD, Finney JW, Asch SM, Humphreys K, Trafton J. Predictive validity of two process-of-care quality measures for residential substance use disorder treatment. Addiction science & clinical practice. 2015 Oct 31; 10(1):22.
123. Humphreys K. An Overdose Antidote Goes Mainstream. Health affairs (Project Hope). 2015 Oct 1; 34(10):1624-7.
124. Trivedi RB, Humphreys K. Participant exclusion criteria in treatment research on neurological disorders: Are unrepresentative study samples problematic? Contemporary clinical trials. 2015 Sep 1; 44:20-25.
125. Humphreys K. Griffith Edwards' rigorous sympathy with Alcoholics Anonymous. Addiction (Abingdon, England). 2015 Jul 1; 110 Suppl 2:16-8.
126. Harris AH, Ellerbe L, Phelps TE, Finney JW, Bowe T, Gupta S, Asch SM, Humphreys K, Trafton J. Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. Journal of substance abuse treatment. 2015 Jun 1; 53:16-21.
127. Andrews C, Abraham A, Grogan CM, Pollack HA, Bersamira C, Humphreys K, Friedmann P. Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform. Health affairs (Project Hope). 2015 May 1; 34(5):828-35.
128. Humphreys K. Addiction Treatment Professionals Are Not the Gatekeepers of Recovery. Substance use & misuse. 2015 Jan 1; 50(8-9):1024-7.
129. Humphreys K, Frank RG. The Affordable Care Act will revolutionize care for substance use disorders in the United States. Addiction (Abingdon, England). 2014 Dec 1; 109(12):1957-8.
130. Humphreys K, Blodgett JC, Wagner TH. Estimating the efficacy of Alcoholics Anonymous without self-selection bias: an instrumental variables re-analysis of randomized clinical trials. Alcoholism, clinical and experimental research. 2014 Nov 1; 38(11):2688-94.
131. Humphreys K. Action is needed to deter the trumpeting of non-peer-reviewed findings to the media. Addiction (Abingdon, England). 2014 May 1; 109(5):691-2.
132. Hoertel N, Falissard B, Humphreys K, Gorwood P, Seigneurie AS, Limosin F. Do clinical trials of treatment of alcohol dependence adequately enroll participants with co-occurring independent mood and anxiety disorders? An analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The Journal of clinical psychiatry. 2014 Mar 1; 75(3):231-7.
133. Humphreys K, Lembke A. Recovery-oriented policy and care systems in the UK and USA. Drug and Alcohol Review. 2014 Jan 1; 33(1):13-8.
134. Humphreys K, Maisel NC, Blodgett JC, Finney JW. Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders. Journal of studies on alcohol and drugs. 2013 Nov 1; 74(6):889-93.
135. Laudet AB, Humphreys K. Promoting recovery in an evolving policy context: what do we know and what do we need to know about recovery support services? Journal of substance abuse treatment. 2013 Jul 1; 45(1):126-33.
136. Rahman I, Humphreys K, Bennet AM, Ingelsson E, Pedersen NL, Magnusson PK. Clinical depression, antidepressant use and risk of future cardiovascular disease. European journal of epidemiology. 2013 Jul 1; 28(7):589-95.
137. Humphreys K, Maisel NC, Blodgett JC, Fuh IL, Finney JW. Extent and reporting of patient nonenrollment in influential randomized clinical trials, 2002 to 2010. JAMA internal medicine. 2013 Jun 10; 173(11):1029-31.
138. Humphreys K. Commentary on Gustafson et al. (2013): can we know that addiction treatment has been improved without evidence of better patient outcomes? Addiction (Abingdon, England). 2013 Jun 1; 108(6):1158-9.
139. Cunningham JA, Neighbors C, Wild C, Humphreys K. Ultra-brief intervention for problem drinkers: results from a randomized controlled trial. PLoS ONE. 2013 Apr 5; 7(10):e48003.
140. Huemer J, Völkl-Kernstock S, Karnik N, Denny KG, Granditsch E, Mitterer M, Humphreys K, Plattner B, Friedrich M, Shaw RJ, Steiner H. Personality and psychopathology in African unaccompanied refugee minors: repression, resilience and vulnerability. Child Psychiatry and Human Development. 2013 Feb 1; 44(1):39-50.
141. Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction (Abingdon, England). 2013 Feb 1; 108(2):275-93.
142. Lembke A, Humphreys KN. Moderation Management: A Mutual Help Organization for Problem Drinkers Who Are Not Alcohol Dependent. Journal of groups in addiction & recovery. 2012 Sep 25; 7(2-4):130-141.
143. Carroll I, Barelka P, Wang CK, Wang BM, Gillespie MJ, McCue R, Younger JW, Trafton J, Humphreys K, Goodman SB, Dirbas F, Whyte RI, Donington JS, Cannon WB, Mackey SC. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesthesia and analgesia. 2012 Sep 1; 115(3):694-702.
144. Harris AH, Oliva E, Bowe T, Humphreys KN, Kivlahan DR, Trafton JA. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatric services (Washington, D.C.). 2012 Jul 1; 63(7):679-85.
145. Humphreys K. Federal policy on criminal offenders who have substance use disorders: how can we maximize public health and public safety? Substance Abuse. 2012 May 17; 33(1):5-8.
146. Söderqvist S, Bergman Nutley S, Peyrard-Janvid M, Matsson H, Humphreys K, Kere J, Klingberg T. Dopamine, working memory, and training induced plasticity: implications for developmental research. Developmental psychology. 2012 May 1; 48(3):836-43.
147. Humphreys K, Piot P. Scientific evidence alone is not sufficient basis for health policy. BMJ (Clinical research ed.). 2012 Feb 27; 344:e1316.
148. Humphreys K. What can we learn from the failure of yet another 'miracle cure' for addiction? Addiction (Abingdon, England). 2012 Feb 1; 107(2):237-9.
149. Strang J, Babor T, Caulkins J, Fischer B, Foxcroft D, Humphreys K. Drug policy and the public good: evidence for effective interventions. Lancet. 2012 Jan 7; 379(9810):71-83.
150. Cunningham JA, Neighbors C, Wild TC, Humphreys K. Normative misperceptions about alcohol use in a general population sample of problem drinkers from a large metropolitan city. Alcohol and Alcoholism. 2012 Jan 1; 47(1):63-6.
151. Humphreys K, McLellan AT. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction (Abingdon, England). 2011 Dec 1; 106(12):2058-66.
152. Cunningham JA, Wild TC, Humphreys K. Who uses online interventions for problem drinkers? Journal of substance abuse treatment. 2011 Oct 1; 41(3):261-4.
153. Humphreys K, Wagner TH, Gage M. If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration. Journal of substance abuse treatment. 2011 Oct 1; 41(3):243-51.
154. Finney JW, Humphreys K, Kivlahan DR, Harris AH. Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy. American journal of public health. 2011 Sep 1; 101(9):1635-42.
155. DuPont RL, Humphreys K. A new paradigm for long-term recovery. Substance Abuse. 2011 Jan 1; 32(1):1-6.
156. Humphreys KN, McLellan AT. Brief intervention, treatment, and recovery support services for Americans who have substance use disorders: An overview of policy in the Obama administration. Psychological Services. 2010 Nov 1; 7(4):275-284.
157. Humphreys KN. But patients like mine were excluded from that trial!: A challenge to evidence-based alcohol treatment. New Directions in the Study of Alcohol Journal. 2010 Oct 1; 34(1):32-36.
158. Barnett PG, Trafton JA, Humphreys K. The cost of concordance with opiate substitution treatment guidelines. Journal of substance abuse treatment. 2010 Sep 1; 39(2):141-9.
159. Drugs and Public Policy Group. Drug Policy and the Public Good: a summary of the book. Addiction (Abingdon, England). 2010 Jul 1; 105(7):1137-45.
160. Cunningham JA, Wild TC, Cordingley J, Van Mierlo T, Humphreys K. Twelve-month follow-up results from a randomized controlled trial of a brief personalized feedback intervention for problem drinkers. Alcohol and Alcoholism. 2010 May 1; 45(3):258-62.
161. Mancino M, Curran G, Han X, Allee E, Humphreys K, Booth BM. Predictors of attrition from a national sample of methadone maintenance patients. The American journal of drug and alcohol abuse. 2010 May 1; 36(3):155-60.
162. Harris AH, Kivlahan DR, Bowe T, Humphreys KN. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatric services (Washington, D.C.). 2010 Apr 1; 61(4):392-8.
163. Melberg HO, Humphreys K. Ineligibility and refusal to participate in randomized trials of treatments for drug dependence. Drug and Alcohol Review. 2010 Mar 1; 29(2):193-201.
164. Harris AH, Humphreys K, Bowe T, Tiet Q, Finney JW. Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes? The journal of behavioral health services & research. 2010 Jan 1; 37(1):25-39.
165. Kelly JF, Kahler C, Humphreys KN. Assessing why substance use disorder patients drop out from or refuse to attend 12-step mutual-help groups: The “REASONS” questionnaire. Addiction research & theory. 2010 Jan 1; 18(3):316-325.
166. Harris AH, Kivlahan DR, Bowe T, Finney JW, Humphreys K. Developing and validating process measures of health care quality: an application to alcohol use disorder treatment. Medical care. 2009 Dec 1; 47(12):1244-50.
167. Humphreys K. Responding to the psychological impact of war on the Iraqi people and U.S. veterans: mixing icing, praying for cake. The American Psychologist. 2009 Nov 1; 64(8):712-23.
168. Harris AH, Bowe T, Finney JW, Humphreys K. HEDIS initiation and engagement quality measures of substance use disorder care: impact of setting and health care specialty. Population health management. 2009 Aug 1; 12(4):191-6.
169. Whelan PJ, Marshall EJ, Ball DM, Humphreys K. The role of AA sponsors: a pilot study. Alcohol and Alcoholism. 2009 Jul 1; 44(4):416-22.
170. Al-Hasnawi SM, Aqrawi R, Sadik S, Humphreys K. Datapoints: Iraqi psychiatrists' perceptions of substance use disorders among patients. Psychiatric services (Washington, D.C.). 2009 Jun 1; 60(6):728.
171. Schutte K, Yano EM, Kilbourne AM, Wickrama B, Kirchner JE, Humphreys K. Organizational contexts of primary care approaches for managing problem drinking. Journal of substance abuse treatment. 2009 Jun 1; 36(4):435-45.
172. Harris AH, Humphreys K, Bowe T, Kivlahan DR, Finney JW. Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure. Journal of substance abuse treatment. 2009 Apr 1; 36(3):294-305.
173. Humphreys K. Searching where the light is worse: overemphasizing genes and underplaying environment in the quest to reduce substance misuse. Clinical pharmacology and therapeutics. 2009 Apr 1; 85(4):357-8.
174. McKay JR, Carise D, Dennis ML, Dupont R, Humphreys K, Kemp J, Reynolds D, White W, Armstrong R, Chalk M, Haberle B, McLellan T, O'Connor G, Pakull B, Schwartzlose J. Extending the benefits of addiction treatment: practical strategies for continuing care and recovery. Journal of substance abuse treatment. 2009 Mar 1; 36(2):127-30.
175. Humphreys K, Harris AH, Kivlahan DR. Performance monitoring of substance use disorder interventions in the Veterans Health Administration. The American journal of drug and alcohol abuse. 2009 Jan 1; 35(3):123-7.
176. Lillis J, Gifford E, Humphreys K, Moos R. Assessing spirituality/religiosity in the treatment environment: the Treatment Spirituality/Religiosity Scale. Journal of substance abuse treatment. 2008 Dec 1; 35(4):427-33.
177. Greenfield TK, Stoneking BC, Humphreys K, Sundby E, Bond J. A randomized trial of a mental health consumer-managed alternative to civil commitment for acute psychiatric crisis. American journal of community psychology. 2008 Sep 1; 42(1-2):135-44.
178. Humphreys K, Harris AH, Weingardt KR. Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. Journal of studies on alcohol and drugs. 2008 Sep 1; 69(5):757-64.
179. Pistrang N, Barker C, Humphreys K. Mutual help groups for mental health problems: a review of effectiveness studies. American journal of community psychology. 2008 Sep 1; 42(1-2):110-21.
180. Cunningham JA, Neighbors C, Wild C, Humphreys K. Ultra-brief intervention for problem drinkers: research protocol. BMC public health. 2008 Aug 26; 8:298.
181. Fogel J, Ribisl KM, Morgan PD, Humphreys K, Lyons EJ. Underrepresentation of African Americans in online cancer support groups. Journal of the National Medical Association. 2008 Jun 1; 100(6):705-12.
182. Humphreys K, Trafton JA, Oliva EM. Does following research-derived practice guidelines improve opiate-dependent patients' outcomes under everyday practice conditions? Results of the Multisite Opiate Substitution Treatment study. Journal of substance abuse treatment. 2008 Mar 1; 34(2):173-9.
183. Harris AH, Humphreys K, Finney JW. Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness. Journal of substance abuse treatment. 2007 Dec 1; 33(4):333-9.
184. Karlin BE, Humphreys K. Improving Medicare coverage of psychological services for older Americans. The American Psychologist. 2007 Oct 1; 62(7):637-49.
185. Trafton JA, Humphreys K, Harris AH, Oliva E. Consistent adherence to guidelines improves opioid dependent patients' first year outcomes. The journal of behavioral health services & research. 2007 Jul 1; 34(3):260-71.
186. Humphreys K, Weingardt KR, Harris AH. Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research. Alcoholism, clinical and experimental research. 2007 Jun 1; 31(6):988-95.
187. Gifford E, Humphreys K. The psychological science of addiction. Addiction. 2007 Mar 1; 102(3):352-61.
188. Trafton JA, Tracy SW, Oliva EM, Humphreys K. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems. Journal of Studies On Alcohol. 2007 Mar 1; 68(2):165-72.
189. Tracy SW, Trafton JA, Weingardt KR, Aton EG, Humphreys K. How are substance use disorders addressed in VA psychiatric and primary care settings? Results of a national survey. Psychiatric services (Washington, D.C.). 2007 Feb 1; 58(2):266-9.
190. Humphreys K, Moos RH. Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcoholism, clinical and experimental research. 2007 Jan 1; 31(1):64-8.
191. Wagner TH, Harris KM, Federman B, Dai L, Luna Y, Humphreys K. Prevalence of drug, alcohol and cigarette use among veterans and comparable non-veterans from the National Survey on Drug Use and Health. Psychological Services. 2007 Jan 1; 4:149-157.
192. Villafranca SW, McKellar JD, Trafton JA, Humphreys K. Predictors of retention in methadone programs: a signal detection analysis. Drug and Alcohol Dependence. 2006 Jul 27; 83(3):218-24.
193. Ilgen MA, Trafton JA, Humphreys K. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug and Alcohol Dependence. 2006 May 20; 82(3):187-93.
194. Humphreys K. The trials of Alcoholics Anonymous. Addiction. 2006 May 1; 101(5):617-8.
195. Cunningham JA, Humphreys K, Kypri K, van Mierlo T. Formative evaluation and three-month follow-up of an online personalized assessment feedback intervention for problem drinkers. Journal of Medical Internet Research [Electronic Resource]. 2006 Apr 12; 8(2):e5.
196. Cunningham JA, Selby PL, Kypri K, Humphreys KN. Access to the Internet among drinkers, smokers and illicit drug users: is it a barrier to the provision of interventions on the World Wide Web? Medical Informatics and The Internet in Medicine. 2006 Mar 1; 31(1):53-8.
197. Trafton JA, Minkel J, Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLoS Medicine. 2006 Mar 1; 3(3):e80.
198. Trafton JA, Minkel J, Humphreys K. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. Journal of Studies On Alcohol. 2006 Mar 1; 67(2):228-35.
199. Humphreys K, Wilbourne P. Knitting together some ripping yarns. Addiction. 2006 Jan 1; 101(1):4-5.
200. Moggi F, Giovanoli A, Sutter M, Humphreys K. Validity and reliability of the German version of the short understanding of substance abuse scale. European Addiction Research. 2005 Oct 1; 11(4):172-9.
201. Cunningham JA, Humphreys K, Koski-Jännes A, Cordingley J. Internet and paper self-help materials for problem drinking: is there an additive effect? Addictive Behaviors. 2005 Sep 1; 30(8):1517-23.
202. Humphreys K, Weingardt KR, Horst D, Joshi AA, Finney JW. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. Addiction. 2005 Sep 1; 100(9):1249-57.
203. Humphreys K. From addiction treatment research reviews to better widgets. Addiction. 2005 Jun 1; 100(6):751-2.
204. Humphreys K. Horizons of the treatment enterprise. Addiction. 2005 Apr 1; 100(4):445-446.
205. Trafton JA, Humphreys K, Kivlahan D, Willenbring M. Barriers to implementation of evidenced-based practice: The case of methadone maintenance. Journal of addictive diseases. 2005 Mar 1; 24:93-108.
206. Harris AH, Thoresen CE, Humphreys K, Faul J. Does writing affect asthma? A randomized trial. Psychosomatic medicine. 2005 Jan 1; 67(1):130-6.
207. Mikami AY, Boucher MA, Humphreys K. Prevention of peer rejection through a classroom-level intervention in middle school. The Journal of Primary Prevention. 2005 Jan 1; 26(1):5-23.
208. Humphreys K. Tale telling in an alcohol mutual help organization. New Directions in the Study of Alcohol Journal. 2004 Dec 1; 29:33-44.
209. McKellar JD, Humphreys K, Piette JD. Depression increases diabetes symptoms by complicating patients' self-care adherence. The Diabetes educator. 2004 May 1; 30(3):485-92.

Journal Other

1. Humphreys K, Calder R, Marsden J, Day E. How Addiction handles disagreements over potentially harmful terminology. Addiction (Abingdon, England). 2023 Oct 1; 118(10):1833-1834.
2. Humphreys K. Commentary on Burke et al. (2020): Safer and less-frequent opioid prescribing are both essential for US public health. Addiction (Abingdon, England). 2020 Mar 1; 115(3):505-506.
3. Vest N, Humphreys KN. Do We Know Enough to Prescribe Opioid-Agonist Therapies to Adolescents With Problematic Opioid Use? A Commentary on Camenga et al. (2019). Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):406-407.
4. Darnall BD, Humphreys KN. An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain. [Letter to the Editor]. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1552-1553.
5. Hall W, West R, Marsden J, Humphreys K, Neale JO, Petry N. The need for more consistent evidential standards in cannabis policy evaluations. [Letter to the Editor]. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1553-1554.
6. Frakt AB, Carroll AE, Pollack HA, Humphreys K. The Rewards and Challenges of Writing for a Mass Media Audience. Health services research. 2018 Oct 1; 53(5):3278-3284.
7. Lembke A, Humphreys K. The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine. Academic Psychiatry : The Journal of The American Association of Directors of Psychiatric Residency Training and The Association For Academic Psychiatry. 2018 Apr 1; 42(2):269-272.
8. Hall W, West R, Marsden J, Humphreys K, Neale J, Petry N. It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. [Editorial]. Addiction (Abingdon, England). 2018 Jun 1; 113(6):987-988.
9. Humphreys K, Darke S, Marsden J, West R. Extending Addiction's conflict of interest policy to cover the emerging cannabis industry. [Editorial]. Addiction (Abingdon, England). 2018 Feb 1; 113(2):205.
10. Humphreys K. Of moral judgments and sexual addictions. [Editorial]. Addiction (Abingdon, England). 2018 Mar 1; 113(3):387-388.
11. Neale J, Humphreys K. Addiction Debates: challenging ideas, challenging ourselves. Addiction (Abingdon, England). 2017 Feb 1; 112(2):204.
12. Caputi TL, Humphreys K. Medicare Recipients' Use Of Medical Marijuana. [Letter to the Editor]. Health affairs (Project Hope). 2016 Oct 1; 35(10):1936.
13. West R, Marsden J, Darke S, Humphreys K, Miller P, Hall W, Petry N. Vote of thanks to Professor Tom Babor. [Editorial]. Addiction. 2015 Jul 1; 110(7):1060.
14. Finney JW, Humphreys K, Harris AH. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality. [Letter to the Editor]. JAMA internal medicine. 2015 Apr 1; 175(4):655-6.
15. Harris AH, Humphreys K, Finney JW. State-level relationships cannot tell us anything about individuals. [Letter to the Editor]. American journal of public health. 2015 Apr 1; 105(4):e8.
16. Babor T, Hall W, Humphreys K, Miller P, Petry N, West R. Who is responsible for the public's health? The role of the alcohol industry in the WHO global strategy to reduce the harmful use of alcohol. [Editorial]. Addiction. 2013 Dec 1; 108(12):2045-7.
17. Finney JW, Humphreys K, Harris AH. Cross-level bias and variations in care. [Letter to the Editor]. JAMA : the journal of the American Medical Association. 2011 Nov 16; 306(19):2096-7; author reply 2097.
18. West R, Miller PG, Babor T, Marsden J, Darke S, Humphreys KN, Edwards G, Hall W. Addiction’s priorities when evaluating submissions. [Editorial]. Addiction. 2011 Feb 7; 106(3):463-465.
19. Humphreys K. Our map should correspond with the territory. Addiction. 2010 Dec 1; 105(12):2054-6; discussion 2056.
20. Humphreys K. Something must be done! But is Moore correct that something can be worse than nothing in alcohol control policy? Alcohol and Alcoholism. 2010 Sep 1; 45(5):409-11.
21. Humphreys KN. Review of research in Alcoholics Anonymous and spirituality in addiction recovery. [Book Review]. Simulation in healthcare : journal of the Society for Simulation in Healthcare. 2010 Jan 1; 18(1):179-180.
22. Humphreys K. Can Dr. Orford's Patient Be Saved? [Editorial]. Addiction. 2008 Jun 1; 103(6):887-888.
23. Humphreys K. Alcohol, Addiction and Christian Ethics. [Book Review]. Addiction. 2007 Nov 19; 102(12):1989-1990.
24. Humphreys K. Hideous Absinthe: A History of a Devil in a Bottle. [Book Review]. Addiction. 2005 May 1; 100(4):564-565.
25. Humphreys K. Thomas de Quincey, Confessions of an English Opium Eater [Book review]. [Editorial]. Addiction. 2004 Sep 1; 99(9):1221-1222.

Books

1. Humphreys KN. Circles of Recovery: Self-Help Organizations for Addictions. International Research Monographs in the Addictions (IRMA). Reissue ed. New York: Cambridge University Press; 2011. 240 p.
2. Marshall EJ, Humphreys KN, Ball DM, Edwards G. The Treatment of Drinking Problems: A Guide to the Helping Professions. 5 ed. New York: Cambridge University Press; 2010. 276 p.
3. Babor TF, Caulkins JP, Edwards G, Fischer B, Foxcroft DR, Humphreys KN, Obot IS, Rehm J, Reuter P, Room R, Rossow I, Strang J. Drug Policy and the Public Good. 1 ed. New York, NY: Oxford University Press; 2010. 368 p.

Book Chapters

1. Kelly J, Humphreys KN, Yeterian J. Mutual-Help Groups. In: Herie M, Skinner WJ, editors. Fundamentals of Addiction: A Practical Guide for Counsellors. 4 ed. Toronto, Canada: Centre on Addiction and Mental Health; 2013. Chapter 14. 791 p.
2. Lembke A, Humphreys KN. What Self-Help Organizations Tell Us About the Syndrome Model of Addiction. In: Shaffer HJ, editor. APA Addiction Syndrome Handbook: APA Handbooks in Psychology. Washington, DC: American Psychological Association; 2012. Volume 2, Part I, Chapter 7.
3. Humphreys KN. Will the Obama Administration Implement a More Health-Oriented Approach to Drug Policy? In: Zedillo E, Wheeler H, editors. Rethinking the "War on Drugs" Through the US-Mexico Prism. New Haven, CT: Yale Center for the Study of Globalization; 2012. Chapter 8. 95-107 p.
4. Humphreys KN, McLellan AT. Forward. In: Kelly JF, White WL, editors. Addiction Recovery Management: Theory, Research and Practice (Current Clinical Psychiatry). New York: Humana Press; 2010. 337 p.
5. Humphreys K, Gifford E. Religion, Spirituality, and the Troublesome Use of Substances. In: Miller WR, Carroll KM, editors. Rethinking Substance Abuse: What the Science Shows, and What We Should Do About It. New York, NY; 2006. Chapter 16. 257-274 p.
6. Kelly J, Humphreys K, Youngson H. Mutual Aid Groups. In: Harrison S, Carver V, editors. Alcohol & Drug Problems: A Practical Guide for Counsellors. 3rd ed. Toronto, Canada: Canadian Addiction and Mental Health Institute; 2004. 169-197 p.
7. Klaw E, Humphreys K. Facilitating client involvement in self-help groups. In: Koocher GP, Norcross JC, Hill SS, editors. Psychologists' Desk Reference. 2nd ed. New York, NY: Oxford University Press; 2004. 502-505 p.
8. Loomis C, Humphreys K. Mutual help organizations for distressed children and their families: A Vygotskian developmental perspective. In: Steiner H, editor. Handbook of Mental Health Interventions in Children and Adolescents: An Integrated Developmental Approach. New York, NY: Wiley; 2004. Chapter 30. 849-871 p.
9. Humphreys K, Timko C, Moos R. Gender differences in the influence of being married on help-seeking and alcohol abuse. In: Rosenqvist P, Blomqvist J, Koski-Jannes A, Ojesjo L, editors. Addiction and the Life Course. Helsinki, Finland: Nordic Council for Alcohol and Drug Research; 2004. 103-116 p.

Online News Media Articles

1. Humphreys KN, Yankah EN. Prisons are getting Whiter. That's one way mass incarceration might end: Getting many Americans to stop seeing prisons as a 'Black problem' is a key to reform. The Washington Post [Internet]. 2021 Feb 26. Available from: https://www.washingtonpost.com/outlook/prisons-are-getting-whiter-thats-one-way-mass-incarceration-might-end/2021/02/26/28db008c-7535-11eb-948d-19472e683521_story.html.
2. Caulkins JP, Humphreys KN. Preventing opioid use and addiction: New thinking and the latest evidence. The Opioid Crisis In America: A paper series from the Foreign Policy and Global Economy & Development programs at Brookings [Internet]. 2020 Jun 22: Available from: Washington, DC.
3. Humphreys KN. Widespread testing might not work in America. We love our 'freedom' too much. The Washington Post. 2020 May 14: Outlook Perspective.
4. Humphreys KN, Caulkins JP, Felbab-Brown V. Order from Chaos: What the US and Canada Can Learn From Other Countries to Combat the Opioid Crisis. Brookings Institution [Internet]. 2020 Jan 13:Order From Chaos(Blog):1. Available from: Washington, DC.
5. Humphreys KN. Yes, marijuana has a gateway effect. But so do most addictive substances. The Washington Post. 2019 Nov 20: Opinion.
6. Humphreys KN. We can't fight opioids by controlling demand alone. Washington Post. 2019 Jul 5.
7. Lane C, Humphreys KN. Black imprisonment rates are down. It's important to know why. Washington Post. 2019 Apr 30.
8. Humphreys KN. Why the price of pot matters to us all: How to improve on Cuomo's legalization framework. New York Daily News. 2019 Jan 18.
9. Humphreys KN. Do supervised drug consumption facilities save lives? Washington Post. 2018 Dec 6.
10. Zulman DM, Humphreys KN. You’re Never too Old to be Studied (Op-Ed). The New York Times. 2014 May 23: A: 23.
11. Humphreys KN. The More You Sleep, The Longer You Live. San Francisco Chronicle. 2007 Sep 2: P-5.
12. Humphreys K, Satel S. Some Gene Research Just Isn't Worth the Money. The New York Times. 2005 Jan 18: Section F, Health & Fitness: 5, Column 1.

Reports

1. White WL, Galanter M, Humphreys KN, Kelly JF. "We do recover": Scientific studies of NA. Blog & New Postings: Narcotic Anonymous. Chestnut Health Systems, Punta Gorda, FL: Selected Papers of William L White Emeritus Sr. Research Consultant; 2020 Apr 10. 56 p.

Center Products

1. Humphreys KN, Finney JW, Sox-Harris AH, Kivlahan DR. What the pot and pain pill overdose study teaches us about ecological fallacies. Mind the Brain Blog, PLOS (Public Library of Science). Blog Entry. 2015 Apr 28.
2. Humphreys KN. The tradeoffs of drug policy. London Drug and Alcohol Policy Forum. London, England, United Kingdom. 2014 Nov 3.
3. Humphreys KN. Choose your drug problem. Closing plenary at Conference on Drugs and Organized Crime: Towards a New Policy Agenda. Chatham House, London, UK. 2012 Jul 3.
4. Humphreys KN. Broom at the top? Using psychology to shape public policy. Presentation for the Conference on Community-Clinical Psychology: Perspectives, Prospects and Challenges. University College, London, England, UK. 2012 Jun 29.
5. Humphreys KN. The evidence base on 12-step facilitation and other recovery-oriented interventions. Drug Intervention Programme Conference, National Treatment Agency for Substance Misuse, Birmingham, England, UK. 2012 Jun 8.
6. Humphreys KN. Motivation from without. Presentation for the New Directions in the Study of Alcohol Group (NDSAG) Conference. Llandindod Wells, Wales, UK. 2012 May 24.
7. Humphreys KN. The evidence for 12-step self-help groups and treatments. Presentation for the 9th UK/European Symposium on Addictive Disorders (UKESAD). London, England, UK. 2012 May 12.
8. Humphreys KN. Peer support and recovery from addiction. Presentation for the Royal College of Psychiatry Meeting: Managing Drug and Alcohol Problems in Primary Care. Cardiff, Wales, UK. 2012 May 11.
9. Humphreys KN. The SAMHSA-MOH partnership in Iraq. Presentation at the US State Department / Iraqi Ministry of Health Drug Demand Reduction Meeting, Beirut, Lebanon. 2012 Apr 15.
10. Humphreys KN. Addiction and Recovery: A Transatlantic perspective. Plenary presentation for Action on Addiction's. 2012 Mar 29.
11. Humphreys KN. The role of treatment in long-term recovery. Presented at the Developing Initiatives Supporting Communities (DISC) Recovery Conference. Leeds, England, UK. 2012 Mar 26.
12. Humphreys KN. Launching a new approach to alcohol-involved violence in London. Presentation to Mayor’s Office for Policing and Crime. London, England, UK. 2012 Mar 21.
13. Humphreys KN. The evidence base for mandatory sobriety. Presentation to House of Lords. London, England, UK. 2012 Mar 12.
14. Humphreys KN. Managing alcohol-involved offenders in England. Presented at: United Kingdom House of Lords Briefing; London, England, UK. 2012 Jan 3.
15. Humphreys KN. Therapeutic jurisprudence with drug and alcohol-involved criminal offenders. Briefing for Prime Minister's Strategy Unit; London, England, UK. 2011 Oct 4.
16. Humphreys KN. A therapeutic jurisprudence approach to alcohol-related violence in the UK. Presented at: United Kingdom House of Lords Briefing; London, England, UK. 2011 Jul 1.
17. Humphreys KN. Payment-by-results and the maximization of drug treatment effectiveness. Presented to: All Party Group on Drugs Misuse, House of Commons, Parliament, London, England, UK. 2011 May 21.
18. Humphreys KN. Can we help Mexico by lowering U.S. drug consumption? Briefing for North American Forum planning group (Co-chairs: former US Secretary of Defense William Perry, and former US Secretary of State George Shultz). Hoover Institution, Stanford, CA. 2011 Apr 2.
19. Humphreys KN. A New Paradigm for Responding to Substance - Involved Offenders. Presented for the London Drug and Alcohol Policy Forum. London, England. 2011 Feb 8.
20. Humphreys KN. Responding to West Virginia’s drug abuse epidemic. Testimony to the West Virginia Senate Committee on Health. 2011 Jan 27.
21. Humphreys KN. Responding to West Virginia’s drug abuse epidemic. Briefing for West Virginia Governor E.R. Tomblin. 2011 Jan 27.
22. Humphreys KN. Responding to West Virginia’s drug abuse epidemic. Testimony to the West Virginia Legislature House of Delegates Committee on Health and Human Resources. 2011 Jan 26.
23. Humphreys KN, McLellan AT. Improving the outcomes of substance use disorder treatment: A policy-oriented review of options for the United Kingdom and the United States. 2010 Nov 3.
24. Humphreys KN, Asch SM. Center for Health Care Evaluation (CHCE). [Website]. 2010 Oct 1.
25. Humphreys KN. The U.S. approach to promoting recovery from addiction. All Party Parliamentary Group on Drug Misuse Meeting; London, United Kingdom. 2010 May 19.
26. Marshall EJ, Ball D, Humphreys KN. What is new in the Treatment of Drinking Problems? Institute of Psychiatry at the Maudsley Panel, London. 2010 Jan 13.
27. Humphreys KN. Promoting quality in addiction treatment. Presented at: All Party Parliamentary Group on Drugs and Alcohol Treatment and Harm Reduction Meeting; London, United Kingdom. 2010 Jan 11.
28. Humphreys KN. Lessons from the VA experience about how the federal Government can improve the treatment of substance use disorders. Presented at: Tory Shadow Cabinet and Backbench Members of Parliament Briefing; Washington, DC. 2009 Nov 22.
29. Lembke A, Humphreys K. Alcoholics Anonymous. In: Kranzler HR, Korsmeyer P, editors. Encyclopedia of Drugs, Alcohol and Addictive Behavior. 3rd ed. New York City, NY: Gale Cengage. 2008 Nov 14.

VA Cyberseminars

1. Humphreys KN. How Exclusion of Women and African-Americans Undermines the Value of Treatment Research. Spotlight on Women's Health [Cyberseminar]. HSR&D. 2015 Dec 10.
2. Bernard R, Humphreys KN, Bohman B. Medical Marijuana: Perspectives and Considerations in Clinical Practice. Offered by Stanford Hospital & Clinics Risk Consulting. [Cyberseminar]. 2011 Mar 1.

Government Briefings

1. Humphreys KN. Opioids, cannabis, and vaping: Using science to protect public health: Briefing before the Joint Hearing of Senate and General Assembly Health and Human Services Committee, State of Rhode Island; 2019 Mar 1; Providence, Rhode Island.
2. Humphreys KN. Medical cannabis, pain, and the opioid epidemic: Briefing before the House and Senate staff; 2018 Oct 15; Washington, DC.
3. Humphreys KN. Promoting effective responses to criminal offenders in and out of prison: Briefing before the UK Prisons Minister Rory Stewart; 2018 Oct 1; London, UK.
4. Humphreys KN. Addiction 101 for Policymakers: Briefing before the 50 cross-committee House and Senate staff members; 2017 Nov 1; Washington, DC.

Conference Presentations

1. Humphreys KN. Addiction Science and Public Policy. Presented at: European Conference on Addictive Behaviours and Dependencies; 2015 Sep 23; Lisbon, Portugal.
2. Sox-Harris AH, Finney JW, Asch SM, Ellerbe L, Phelps T, Bowe T, Gupta S, Humphreys KN, Trafton JA. Predictive Validity of Two Process Quality Measures for Residential Substance Use Disorder Treatment. Paper presented at: AcademyHealth Annual Research Meeting; 2015 Jun 14; Minneapolis, MN.
3. Humphreys KN. The future of research on addiction mutual help organizations and the subjective experience of recovery. Presented at: Swiss Society of Addiction Medicine Conference on the Addictions (Berner Suchtkongress); 2015 Jun 11; Bern, Switzerland.
4. Humphreys KN. Two U.S. case studies of mental health care systems and policy change. Presented at: International Conference on the Treatment of Addictive Behaviours; 2015 Jun 2; Odense, Denmark.
5. Humphreys KN. Alcohol is our guns: The Post-Election Future of UK Alcohol Policy. Addicted to Recovery? Presented at: New Directions in the Study of Alcohol Group Annual Conference; 2015 May 21; London, England.
6. Humphreys KN. Recent developments in federal mental health policy. Presented at: Association of Health Care Journalists Annual Meeting; 2015 Apr 23; Santa Clara, CA.
7. Humphreys KN. Circles of Recovery: Mutual Help Organizations for Substance Use Disorders. Presented at: University of Chicago School for Social Service Administration Center for Health Administration Studies Michael M. Davis Seminar Series; 2015 Mar 31; Chicago, IL.
8. Humphreys KN. Toward more and better addiction treatment. Presented at: Conscious Healing Innovations: Advancements in Addiction Treatment Conference; 2015 Mar 27; Windsor, CA.
9. Humphreys KN. How psychologists can improve public policies regarding people with addiction and mental illness. Presented at: San Jose State University Alan E. Kazdin Endowed Lecture in Psychology; 2015 Mar 17; San Jose, CA.
10. Humphreys KN. The evolution of treatment for drug addiction. What Are the Key Lessons Learned in the Forty-Year War on Drugs? Presented at: Harvard University Radcliffe Institute for Advanced Study Exploratory Seminar; 2015 Jan 29; Cambridge, MA.
11. Humphreys KN, Hawkins III JR, McLellan T, Middlebrook BA. The history and evolution of policy towards Veterans with addictive and psychiatric disorders. Presented at: American Bar Association Annual Washington Health Law Summit; 2014 Dec 8; Washington, DC.
12. Humphreys KN. Damned If We Do... Can We Relieve Pain and Stop Opioid Abuse At the Same Time? Presented at: Conquering Pain Locally, Regionally and Nationally Conference; 2014 Sep 19; Stanford, CA.
13. Harris AH, Finney J, Asch S, Ellerbe L, Phelps T, Bowe T, Gupta S, Humphreys K, Trafton J. Predictive Validity of New Measures of Addiction Treatment Quality. Presented at: Addiction Health Services Research Conference; 2013 Oct 24; Portland, OR.
14. Harris AH, Finney J, Asch S, Ellerbe L, Phelps T, Bowe T, Gupta S, Humphreys K, Trafton J. Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. Presented at: Addiction Health Services Research Conference; 2013 Oct 24; Portland, OR.
15. Humphreys KN. Responding to opioid and methamphetamine addiction. Paper presented at: Kanawha County Methamphetamine Task Force Meeting; 2013 Sep 19; Charleston, WV.
16. Humphreys KN. Evidence-informed substance abuse prevention and treatment policy. Presented at: West Virginia Department of Health and Human Resources Integrated Behavioral Health Conference; 2013 Sep 17; Charleston, WV.
17. Humphreys KN. The Role of Subjective Experience and Identity Change in Mutual Help Organizations. Presented at: Research Institute for Public Health and Addiction International Conference; 2013 Sep 9; Zurich, Switzerland.
18. Humphreys KN. Public Policy towards People with Addictive and Psychiatric Disorders. Presented at: Stanford Sleep Epidemiology Research Center Public Mental Health Symposium; 2013 Aug 30; Palo Alto, CA.
19. Harris AH, Finney JW, Asch SM, Ellerbe L, Phelps T, Bowe T, Gupta S, Humphreys KN, Trafton JA. Validating new measures of addiction treatment quality. Poster session presented at: AcademyHealth Annual Research Meeting; 2013 Jun 23; Baltimore, MD.
20. White W, Humphreys KN, Bourgeois M, Chiapella P, Evan A, Flaherty M, Gaumond P, Haggerson P, Haberle B, Hill T, Kaskutas LA, Kelly J, McDaid C, Powell J, Scott C, Taylor P. The status and future of addiction recovery support services in the United States. Betty Ford Institute Consensus Statement. Presented at: Betty Ford Institute Consensus Annual Conference; 2013 Jun 17; Palm Springs, CA.
21. Humphreys KN. An evidenced-informed policy approach for alcohol in Britain. Co-presentation with the Baroness Finlay of Llandaff. Presented at: Alcohol Research UK Annual Conference; 2013 Mar 12; London, United Kingdom.
22. Humphreys KN. Public policy on prescription opioids: Are we trapped between Scylla and Charybdis? Invited Plenary. Presented at: American Academy of Pain Medicine Annual Meeting; 2012 Feb 25; Palm Springs, CA.
23. Humphreys KN. Patients versus subjects in treatment research. Presented at: University of Chicago School for Social Service Administration Center for Health Administration Studies Michael M. Davis Seminar Series; 2012 Jan 30; Chicago, IL.
24. Humphreys KN. How unrepresentative samples reduce the generalizability of treatment outcome research. Presented at: University of Arkansas Medical School Department of Psychiatry Grand Rounds; 2012 Jan 26; Little Rock, AR.
25. Harris AH, Humphreys KN, Oliva EM, Bowe T, Kivlahan D, Trafton JA. Pharmacotherapy for Alcohol Use Disorders in the Veterans Health Administration (VHA): Patterns of Receipt and Patient Persistence. Poster session presented at: AcademyHealth Annual Research Meeting; 2011 Jun 15; Seattle, WA.
26. Harris AH, Humphreys KN, Oliva EM, Fernandes-Taylor S, Bowe T, Kivlahan D, Trafton JA. Comparing Alternative Metrics for Monitoring Pharmacotherapy of Alcohol Use Disorders: Effects on Overall Performance and Facility Rank Order. Poster session presented at: AcademyHealth Annual Research Meeting; 2011 Jun 15; Seattle, WA.
27. Humphreys KN. Payment by Results: Strategies to Improve Outcomes for Substance-Use Disorder Patients. Paper presented at: United Kingdom / European Symposium on Addictive Disorders; 2011 May 20; London, England.
28. Humphreys KN. Will the Obama Administration adopt a more health-oriented response to drugs? Paper presented at: Yale Center for the Study of Globalization: Rethinking the "War on Drugs" through the US-Mexico Prism Conference; 2011 May 12; New Haven, CT.
29. Humphreys KN. Responding to Substance Use Disorders in Military Personnel and their Dependents. Paper presented at: Institute of Medicine: Prevention, Diagnosis, Treatment and Management of Substance Use Disorders in the U.S. Armed Forces Conference; 2011 Mar 30; Washington, DC.
30. Humphreys KN. The changing landscape of addiction treatment in the United States, an ONDCP perspective. Presented at: Phoenix House Foundation State of the Field Meeting; 2010 Dec 1; New York, NY.
31. Humphreys KN. Managing Substance Use Disorders in Primary Care: Lessons from Developed and Developing Countries. Presented at: World Congress of Social Psychiatry; 2010 Oct 26; Marrakech, Morocco.
32. Humphreys KN. Policies that promote effective systems of care for substance use. Paper presented at: Addiction Health Services Research Conference; 2010 Oct 1; San Francisco, CA.
33. Humphreys KN. Bridges to the next Government. Panel with David Burrowes, MP and Baroness Doreen Massey. Presented at: United Kingdom / European Symposium on Addictive Disorders; 2010 May 20; London, England.
34. Humphreys KN. Opiate agonist treatment and the national drug control strategy. Presented at: National Institute on Drug Abuse / Center for Substance Abuse Treatment Buprenorphine Summit; 2010 May 11; Washington, DC.
35. Humphreys KN. The drug strategy and public health. Paper presented at: National Advisory Council for Healthcare Research and Quality / Center for Substance Abuse Treatment Meeting; 2010 Apr 14; Rockville, MD.
36. Humphreys KN. The role of screening and brief intervention in White House Policy. Presented at: Centers for Disease Control and Prevention Panel Meeting; 2010 Apr 12; Washington, DC.
37. Humphreys KN. Clinical trial design and the problem of unrepresentative samples. Presented at: Oxford-Brookes University School of Health and Social Care Seminar; 2010 Mar 29; Oxford, United Kingdom.
38. Humphreys KN. Policies for improving systems of care for substance use disorders. Presented at: International Society for the Study of Drug Policy Annual Conference; 2010 Mar 23; Santa Monica, CA.
39. Humphreys KN. What is the future of performance promotion research? Presented at: National Institute on Drug Abuse Substance Abuse Health Services Research Annual Conference; 2010 Mar 19; Bethesda, MD.
40. Finney JW, Humphreys KN, Kivlahan DR, Harris AH. Differences between patient-level and facility-level performance measure-outcome relationships: Implications for quality measurement and management. Poster session presented at: Treatment of Addictive Behaviors Annual International Conference; 2010 Feb 9; Santa Fe, NM.
41. Finney JW, Humphreys KN, Kivlahan DR, Harris AH. Differences between patient-and facility-level performance measure-outcome relationships: Implications for health care quality management and research. Paper presented at: Kaiser Permanente Division of Research Annual Meeting; 2010 Jan 5; Oakland, CA.
42. Humphreys KN. How the Obama Administration will Promote and Celebrate Recovery from Addiction. Presented at: Recovery Community Services Program / Recovery-Oriented Systems of Care Grantee Conference; 2009 Nov 30; Gaithersburg, MD.
43. Humphreys KN. The future of international treatment policy. Paper presented at: Society for the Study of Addiction Annual Symposium; 2009 Nov 11; York, United Kingdom.
44. Humphreys KN. The role of science in policy making. Paper presented at: Association for Public Policy Analysis and Management Annual Conference; 2009 Nov 5; Washington, DC.
45. Finney JW, Humphreys KN, Kivlahan DR, Harris AH. Incongruence between patient-level and facility-level performance measure-outcome relationships: Implications for quality management and research. Poster session presented at: Addiction Health Services Research Conference; 2009 Oct 29; San Francisco, CA.
46. Humphreys KN. Policies that promote effective systems of care for substance use disorder. Presented at: International Council on Alcohol and Addictions Annual Conference; 2009 Oct 12; Estoril, Portugal.
47. Humphreys KN. But patients like mine were excluded from that trial!: A challenge to evidence-based addiction treatment. Paper presented at: New Directions in the Study of Alcohol Group Annual Conference; 2009 Apr 23; Belfast, Ireland.
48. Humphreys KN. One flew over the is-ought gap: Why many academics underestimate the influence of science on U.S. drug policy. Paper presented at: International Society for the Study of Drug Policy Annual Conference; 2009 Mar 1; Vienna, Austria.
49. Humphreys KN. Why cost offset studies do not convince medical centers to expand treatment for substance use disorders. Paper presented at: Society for the Study of Addiction Annual Symposium; 2008 Nov 12; York, United Kingdom.
50. Harris AH, Bowe T, Humphreys KN. Medication Treatment of Alcohol Use Disorders in the Veterans Health Administration. Paper presented at: Addiction Health Services Research Conference; 2008 Oct 21; Boston, MA.
51. Humphreys KN. Addiction in Iraq. Paper presented at: Centre for Addiction and Mental Health Colloquium; 2008 Oct 1; Toronto, Canada.
52. Harris AHS, Humphreys KH, Bowe T, Kivlahan D, Hyun J, Finney JW. Developing a New Quality Measure of Outpatient Addiction Treatment for the VA. Presented at: AcademyHealth Annual Research Meeting; 2008 Jun 8; Washington, DC.
53. Humphreys K. The Status of Mental Health Services in Iraq. Paper presented at: Embassy of Iraq and Coalition Government International Iraq Health Annual Summit; 2008 May 20; Washington, DC.
54. Carroll I, Wang J, Wang C, Gillespie M, Barelka P, Humphreys K, Trafton J. Risk factors for delayed opioid cessation following surgery. Poster session presented at: American Pain Society Annual Meeting; 2008 May 9; Tampa, FL.
55. Carroll I, Wang J, Wang C, Gillespie M, Barelka P, Humphreys K, Trafton J, Dirbas F, Goodman S, Whyte R, Cannon W, Yang G, Pollard J, Mackey S. Psychological impairment influences pain duration following surgical injury. Poster session presented at: American Pain Society Annual Meeting; 2008 May 9; Tampa, FL.
56. Humphreys K. Is it in Medical Centers' Economic Self-Interest to Provide Drug Treatment?: A Cost-Consequence Study from a National Health Care System. Paper presented at: International Society for the Study of Drug Policy Annual Conference; 2008 Apr 3; Lisbon, Portugal.
57. Harris A, Humphreys K, Bowe T, Kivlahan D, Finney J. Measuring the Quality of Substance Use Disorder Treatment: Assessing the VA Continuity of Care Performance Measure. Poster session presented at: VA HSR&D National Meeting; 2008 Feb 13; Baltimore, MD.
58. Humphreys K. Circles of Recovery: What Does Science Tell Us About Self-Help Groups for Addictions. Paper presented at: Association for Medical Education and Research in Substance Abuse Annual Meeting; 2007 Nov 8; Washington, DC.
59. Harris AH, Humphreys K, Bowe T, Kivlahan D, Finney JW. Measuring the Quality of Addiction Treatment: Assessing the VA Continuity of Care Quality Measure. Paper presented at: Addiction Health Services Research Conference; 2007 Oct 16; Athens, GA.
60. Humphreys K. Continuity of Care Guidelines for Participation in Mutual Help Organizations Before, During and After Addiction Treatment. Paper presented at: Betty Ford Institute Consensus Annual Conference; 2007 Oct 10; Palm Springs, CA.
61. Humphreys K. Culture, Spirituality and Mutual Help for Addiction. Paper presented at: Self-Help Groups for Alcohol and Drugs Annual Conference; 2007 Oct 1; Alessandria, Italy.
62. Harris AHS, Bowe T, Humphreys KN. Characteristics of VA substance use disorder (SUD) patients who initiate and engage in treatment. Poster session presented at: American Psychological Association Annual Convention; 2007 Aug 19; San Francisco, CA.
63. Harris AHS, Humphreys KN, Finney JW. Veterans Affairs facility performance on Washington circle indicators and casemix-adjusted effectiveness. Poster session presented at: American Psychological Association Annual Convention; 2007 Aug 19; San Francisco, CA.
64. Humphreys KN. Expanding the universe of alternatives for internship training. Paper presented at: American Psychological Association Annual Convention; 2007 Aug 18; San Francisco, CA.
65. Wagner TH, Gage M, Humphreys K. The economic consequences for medical centers that change their mix of substance use treatment services. Paper presented at: Bay Area Health Care Quality and Outcomes Annual Meeting; 2007 May 22; San Francisco, CA.
66. Humphreys K, Wagner TH, Schaefer J, Gage M. The decision to expand substance abuse treatment services: Assessing impact from the policymaker's perspective. Presented at: International Society for the Study of Drug Policy Annual Conference; 2007 Mar 22; Oslo, Norway.
67. Humphreys K. Toward empirically informed treatments for drug and alcohol dependence. Paper presented at: Georgetown University Health Policy Institute Annual Series; 2007 Jan 15; Washington, DC.
68. Humphreys K. Is research promoting progress in the addiction treatment field? Paper presented at: King's College of London Institute of Psychiatry at Maudsley Annual Meeting; 2006 Dec 15; London, England.
69. Humphreys K. Drug abuse and treatment in Iraq. Paper presented at: Delivery Systems for Substance Abuse Treatment International Annual Conference; 2005 Sep 1; Istanbul, Turkey.
70. Humphreys K. Professional Perspective on Alcoholics Anonymous. Paper presented at: Alcoholics Anonymous International Annual Convention; 2005 Jul 1; Toronto, Canada.
71. Humphreys K, Trafton JA, Oliva E. Does following practice guidelines matter in the real world of heroin dependence treatment: Multisite Opioid Substitution Treatment Study. Paper presented at: VA HSR&D National Meeting; 2005 Jun 26; Boston, MA.
72. Trafton JA, Minkel JD, Humphreys K. Posttraumatic stress disorder does not impair substance use disorder outcomes in opioid substitution treatment. Paper presented at: VA HSR&D National Meeting; 2005 Jun 26; Boston, MA.
73. Humphreys K. Circles of Recovery. Paper presented at: West Kent National Health Service and Social Care Trust Annual Symposium; 2005 May 1; Maidstone, England.
74. Humphreys K. 12-step mutual support organizations for addictions. Paper presented at: International Society of Addiction Medicine Annual Meeting; 2005 Apr 1; Buenos Aires, Argentina.
75. Humphreys K. Creating a health care informatics system for Iraq. Paper presented at: Action Planning for Iraq Mental Health Annual Conference; 2005 Mar 15; Amman, Jordan.
76. Humphreys K, Trafton J, Oliva E. Does following clinical practice guidelines matter in the real world of heroin dependence treatment? Paper presented at: VA HSR&D National Meeting; 2005 Feb 1; Baltimore, MD.
77. Markie P, Humphreys K, Suchinsky RS. Drug control programs in the Department of Veterans Affairs. Paper presented at: U. S. House of Representatives Subcommittee on Criminal Justice, Drug Policy and Human Resources, Government Reform Committee Annual Briefing; 2004 Dec 1; Washington, DC.
78. Humphreys K. Twelve-step groups, spirituality, and recovery from addiction. Paper presented at: Addiction Medicine Annual Conference; 2004 Oct 1; White Plains, NY.
79. Humphreys K, Gifford EV. How can religious and mutual help organizations combat troublesome use of substances? Paper presented at: Approaches for Combating the Troublesome Use of Substances (CACTUS) Annual Conference; 2004 Oct 1; Albuquerque, NM.
80. Gifford EV, Waldroup WM, Humphreys KN. Religion, spirituality, and culturally sensitive addiction interventions in minority communities. Poster session presented at: American Psychological Association Annual Convention; 2004 Aug 1; Honolulu, HI.
81. Harris A, Thoresen CE, Humphreys K, Faul J. Effects of Expressive Writing on Lung Function in Adult Asthmatics. Paper presented at: American Psychological Association Annual Convention; 2004 Aug 1; Honolulu, HI.
82. Humphreys K. Storytelling in an alcohol self-help organizations. Paper presented at: New Directions in the Study of Alcohol Group Annual Conference; 2004 Apr 1; Wales, United Kingdom.

DRA: Substance Use Disorders, Mental, Cognitive and Behavioral Disorders
DRE: Treatment - Observational
Keywords: Career Development
MeSH Terms: none